nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.106	0.117	CbGpPWpGaD
Triflupromazine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.104	0.116	CbGpPWpGaD
Triflupromazine—HTR2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0335	0.0372	CbGpPWpGaD
Triflupromazine—DRD1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0316	0.0351	CbGpPWpGaD
Triflupromazine—HTR2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0282	0.0313	CbGpPWpGaD
Triflupromazine—DRD1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0266	0.0295	CbGpPWpGaD
Triflupromazine—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0239	0.0265	CbGpPWpGaD
Triflupromazine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0233	0.026	CbGpPWpGaD
Triflupromazine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.023	0.0256	CbGpPWpGaD
Triflupromazine—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0201	0.0223	CbGpPWpGaD
Triflupromazine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0196	0.0218	CbGpPWpGaD
Triflupromazine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0194	0.0215	CbGpPWpGaD
Triflupromazine—Propiomazine—CHRM3—nephrolithiasis	0.0156	0.155	CrCbGaD
Triflupromazine—Chlorprothixene—CHRM3—nephrolithiasis	0.0147	0.147	CrCbGaD
Triflupromazine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0143	0.0159	CbGpPWpGaD
Triflupromazine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0141	0.0157	CbGpPWpGaD
Triflupromazine—Methotrimeprazine—CHRM3—nephrolithiasis	0.0133	0.133	CrCbGaD
Triflupromazine—Promethazine—CHRM3—nephrolithiasis	0.0131	0.131	CrCbGaD
Triflupromazine—Desipramine—CHRM3—nephrolithiasis	0.0119	0.119	CrCbGaD
Triflupromazine—HTR2B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0116	0.0129	CbGpPWpGaD
Triflupromazine—Promazine—CHRM3—nephrolithiasis	0.0115	0.115	CrCbGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0103	0.0115	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.0102	0.0114	CbGpPWpGaD
Triflupromazine—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0102	0.0113	CbGpPWpGaD
Triflupromazine—Chlorpromazine—CHRM3—nephrolithiasis	0.0102	0.101	CrCbGaD
Triflupromazine—Imipramine—CHRM3—nephrolithiasis	0.0101	0.101	CrCbGaD
Triflupromazine—DRD1—G alpha (s) signalling events—PTH—nephrolithiasis	0.01	0.0111	CbGpPWpGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00981	0.0109	CbGpPWpGaD
Triflupromazine—HTR2B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00836	0.0093	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00806	0.00896	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00748	0.00832	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00721	0.00802	CbGpPWpGaD
Triflupromazine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00699	0.00777	CbGpPWpGaD
Triflupromazine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00699	0.00777	CbGpPWpGaD
Triflupromazine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.0069	0.00767	CbGpPWpGaD
Triflupromazine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0069	0.00767	CbGpPWpGaD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00647	0.00719	CbGpPWpGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0061	0.00678	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00583	0.00648	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00554	0.00616	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00522	0.00581	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00521	0.0058	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00488	0.00543	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0046	0.00512	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.0046	0.00512	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00451	0.00501	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00445	0.00494	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00443	0.00493	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00422	0.00469	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00418	0.00465	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00398	0.00442	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00394	0.00438	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00389	0.00432	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00389	0.00432	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00386	0.00429	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.00386	0.00429	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00381	0.00424	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00364	0.00404	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00348	0.00386	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00347	0.00385	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.0034	0.00378	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00336	0.00373	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.0033	0.00367	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00317	0.00352	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00317	0.00352	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00316	0.00351	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00311	0.00346	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00309	0.00343	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00308	0.00342	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.00305	0.00339	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.003	0.00334	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00299	0.00333	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00294	0.00327	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.0029	0.00323	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.0029	0.00323	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GRHPR—nephrolithiasis	0.00283	0.00314	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00282	0.00314	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.00275	0.00305	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00269	0.00299	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.00265	0.00295	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.00262	0.00291	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AGXT—nephrolithiasis	0.00252	0.0028	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.00247	0.00275	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0024	0.00267	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0024	0.00267	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00238	0.00265	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00235	0.00261	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.0023	0.00255	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00227	0.00252	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00225	0.0025	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00223	0.00248	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00223	0.00248	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.00219	0.00244	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00218	0.00242	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00216	0.00241	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.00215	0.00239	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—SLC26A1—nephrolithiasis	0.00214	0.00238	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APRT—nephrolithiasis	0.00214	0.00238	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.00213	0.00237	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.00212	0.00236	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.00209	0.00232	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.00206	0.00229	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.00206	0.00229	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00204	0.00227	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00199	0.00221	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00199	0.00221	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.00198	0.0022	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.00187	0.00208	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.00186	0.00207	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.00182	0.00203	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.0018	0.002	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00177	0.00197	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.00177	0.00197	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0017	0.00189	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.00167	0.00185	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00167	0.00185	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00166	0.00185	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00164	0.00182	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00159	0.00177	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.00155	0.00173	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00154	0.00171	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AQP1—nephrolithiasis	0.00153	0.0017	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.00152	0.00169	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00151	0.00168	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	0.0015	0.00167	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00149	0.00166	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00141	0.00157	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CHRM3—nephrolithiasis	0.00138	0.00154	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.00138	0.00153	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	0.00138	0.00153	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	0.00136	0.00151	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.00128	0.00142	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.00126	0.0014	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00126	0.0014	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	0.00123	0.00137	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00123	0.00137	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.00123	0.00137	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	0.00122	0.00135	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00122	0.00135	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.00121	0.00134	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.00117	0.0013	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.0011	0.00123	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.00105	0.00116	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APRT—nephrolithiasis	0.00105	0.00116	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000911	0.00101	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.000891	0.000991	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	0.00088	0.000978	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000833	0.000926	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	0.000815	0.000906	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	0.000805	0.000894	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000745	0.000829	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000674	0.000749	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	0.000587	0.000653	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000554	0.000616	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000418	0.000465	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	0.000409	0.000455	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	0.000404	0.000449	CbGpPWpGaD
